Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05501769
Title ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer (TACTIVE-E)
Acronym TACTIVE-E
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arvinas Estrogen Receptor, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Clinical Trial Site San Diego California 92037 United States Details
Clinical Trial Site Santa Monica California 90404 United States Details
Clinical Trial Site Washington District of Columbia 20007 United States Details
Clinical Trial Site Lake Mary Florida 32746 United States Details
Clinical Trial Site Ann Arbor Michigan 48109 United States Details
Clinical Trial Site Nashville Tennessee 37203 United States Details
Clinical Trial Site Barcelona 08028 Spain Details
Clinical Trial Site Madrid 28034 Spain Details
Clinical Trial Site Valencia 46018 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field